This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2011:78:415-47.

doi: 10.1002/9781118105771.ch10.

Irreversible inhibitors of tissue transglutaminase

Jeffrey W Keillor¹, Nicolas Chabot, Isabelle Roy, Amina Mulani, Olivier Leogane, Christophe Pardin

Affiliations

PMID: 22220480
DOI: 10.1002/9781118105771.ch10

Review

Irreversible inhibitors of tissue transglutaminase

Jeffrey W Keillor et al. Adv Enzymol Relat Areas Mol Biol. 2011.

. 2011:78:415-47.

doi: 10.1002/9781118105771.ch10.

Authors

Jeffrey W Keillor¹, Nicolas Chabot, Isabelle Roy, Amina Mulani, Olivier Leogane, Christophe Pardin

Affiliation

¹ Department of Chemistry, University of Montréal, Montréal, QC, Canada.

PMID: 22220480
DOI: 10.1002/9781118105771.ch10

No abstract available

PubMed Disclaimer

Similar articles

Dihydroisoxazole analogs for labeling and visualization of catalytically active transglutaminase 2.
Dafik L, Khosla C. Dafik L, et al. Chem Biol. 2011 Jan 28;18(1):58-66. doi: 10.1016/j.chembiol.2010.11.004. Chem Biol. 2011. PMID: 21276939 Free PMC article.
Potent transglutaminase inhibitors, dithio β-aminoethyl ketones.
Ozaki S, Ebisui E, Hamada K, Suzuki AZ, Terauchi A, Mikoshiba K. Ozaki S, et al. Bioorg Med Chem Lett. 2011 Jan 1;21(1):377-9. doi: 10.1016/j.bmcl.2010.10.136. Epub 2010 Oct 31. Bioorg Med Chem Lett. 2011. PMID: 21134746
Discovery of potent and specific dihydroisoxazole inhibitors of human transglutaminase 2.
Klöck C, Herrera Z, Albertelli M, Khosla C. Klöck C, et al. J Med Chem. 2014 Nov 13;57(21):9042-64. doi: 10.1021/jm501145a. Epub 2014 Oct 31. J Med Chem. 2014. PMID: 25333388 Free PMC article.
Recent Progress in the Development of Transglutaminase 2 (TGase2) Inhibitors.
Song M, Hwang H, Im CY, Kim SY. Song M, et al. J Med Chem. 2017 Jan 26;60(2):554-567. doi: 10.1021/acs.jmedchem.6b01036. Epub 2016 Nov 21. J Med Chem. 2017. PMID: 28122456 Review.
Transglutaminase as a therapeutic target for celiac disease.
Sulic AM, Kurppa K, Rauhavirta T, Kaukinen K, Lindfors K. Sulic AM, et al. Expert Opin Ther Targets. 2015 Mar;19(3):335-48. doi: 10.1517/14728222.2014.985207. Epub 2014 Nov 20. Expert Opin Ther Targets. 2015. PMID: 25410283 Review.

See all similar articles

Cited by

Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease.
Prime ME, Brookfield FA, Courtney SM, Gaines S, Marston RW, Ichihara O, Li M, Vaidya D, Williams H, Pedret-Dunn A, Reed L, Schaertl S, Toledo-Sherman L, Beconi M, Macdonald D, Muñoz-Sanjuan I, Dominguez C, Wityak J. Prime ME, et al. ACS Med Chem Lett. 2012 Aug 9;3(9):731-5. doi: 10.1021/ml3001352. eCollection 2012 Sep 13. ACS Med Chem Lett. 2012. PMID: 24900540 Free PMC article.
Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity.
Rorke EA, Adhikary G, Szmacinski H, Lakowicz JR, Weber DJ, Godoy-Ruiz R, Puranik P, Keillor JW, Gates EWJ, Eckert RL. Rorke EA, et al. Mol Carcinog. 2022 Jan;61(1):19-32. doi: 10.1002/mc.23356. Epub 2021 Oct 5. Mol Carcinog. 2022. PMID: 34610184 Free PMC article.
Structure-Activity Relationships of Potent, Targeted Covalent Inhibitors That Abolish Both the Transamidation and GTP Binding Activities of Human Tissue Transglutaminase.
Akbar A, McNeil NMR, Albert MR, Ta V, Adhikary G, Bourgeois K, Eckert RL, Keillor JW. Akbar A, et al. J Med Chem. 2017 Sep 28;60(18):7910-7927. doi: 10.1021/acs.jmedchem.7b01070. Epub 2017 Sep 14. J Med Chem. 2017. PMID: 28858494 Free PMC article.
Transglutaminase 2 function in glioblastoma tumor efferocytosis.
Lui M, Sevinc F, Elgafarawi M, Munoz DG, Keillor JW, Sinclair J, Catana D, Alhuthayl M, Woulfe J, Lorimer IA. Lui M, et al. Cell Death Dis. 2025 Jul 3;16(1):487. doi: 10.1038/s41419-025-07819-2. Cell Death Dis. 2025. PMID: 40610434 Free PMC article.
In silico studies of the open form of human tissue transglutaminase.
Ivashchenko SD, Shulga DA, Ivashchenko VD, Zinovev EV, Vlasov AV. Ivashchenko SD, et al. Sci Rep. 2024 Jul 10;14(1):15981. doi: 10.1038/s41598-024-66348-8. Sci Rep. 2024. PMID: 38987418 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database